Arceo, Erwin D.
HRN: 22-51-95 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2023
CEFUROXIME 500MG (TAB)
02/05/2023
02/12/2023
ORAL
500mg
TID
S/p Open Reduction Of Zygomaticmaxillary Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes